DD279674A5 - Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen - Google Patents

Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen Download PDF

Info

Publication number
DD279674A5
DD279674A5 DD87309128A DD30912887A DD279674A5 DD 279674 A5 DD279674 A5 DD 279674A5 DD 87309128 A DD87309128 A DD 87309128A DD 30912887 A DD30912887 A DD 30912887A DD 279674 A5 DD279674 A5 DD 279674A5
Authority
DD
German Democratic Republic
Prior art keywords
salt
hydrogen
formula
ethyl
hydroxy
Prior art date
Application number
DD87309128A
Other languages
German (de)
English (en)
Inventor
Wolfgang Froestl
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD279674A5 publication Critical patent/DD279674A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD87309128A 1986-06-26 1987-11-17 Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen DD279674A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH258886 1986-06-26

Publications (1)

Publication Number Publication Date
DD279674A5 true DD279674A5 (de) 1990-06-13

Family

ID=4237161

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87309128A DD279674A5 (de) 1986-06-26 1987-11-17 Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen

Country Status (16)

Country Link
EP (1) EP0252005B1 (sv)
JP (1) JPH0699420B2 (sv)
AT (1) ATE65084T1 (sv)
AU (1) AU617988B2 (sv)
CA (1) CA1322553C (sv)
CY (1) CY1783A (sv)
DD (1) DD279674A5 (sv)
DE (1) DE3771280D1 (sv)
DK (1) DK325587A (sv)
ES (1) ES2044970T3 (sv)
FI (1) FI91064C (sv)
GR (1) GR3002308T3 (sv)
HK (1) HK134994A (sv)
HU (1) HU207061B (sv)
IE (1) IE59881B1 (sv)
PT (1) PT85157B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
EP0389425B1 (de) * 1989-03-22 1995-04-26 Ciba-Geigy Ag Neue Benzothiopyranylamine
US5189179A (en) 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2694005B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JP3546657B2 (ja) * 1997-08-29 2004-07-28 株式会社トヨトミ 給湯機の缶体構造
JP2008524276A (ja) * 2004-12-20 2008-07-10 エフ.ホフマン−ラ ロシュ アーゲー 4−アミノピペリジン誘導体
US10258598B2 (en) 2014-12-05 2019-04-16 Semmelweis University Compounds for use in the prevention or treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
GB1520801A (en) * 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
DE3411993A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
JPH0816108B2 (ja) * 1986-02-21 1996-02-21 株式会社クラレ 3,4−ジヒドロ−2h−ベンゾピラン誘導体及びその医薬用途

Also Published As

Publication number Publication date
DK325587D0 (da) 1987-06-25
PT85157A (en) 1987-07-01
EP0252005B1 (de) 1991-07-10
HK134994A (en) 1994-12-09
JPS638382A (ja) 1988-01-14
ES2044970T3 (es) 1994-01-16
GR3002308T3 (en) 1992-12-30
CA1322553C (en) 1993-09-28
HUT48622A (en) 1989-06-28
IE871694L (en) 1987-12-26
DK325587A (da) 1987-12-27
FI872807A0 (sv) 1987-06-24
DE3771280D1 (de) 1991-08-14
FI91064C (sv) 1994-05-10
HU207061B (en) 1993-03-01
EP0252005A1 (de) 1988-01-07
IE59881B1 (en) 1994-04-20
ATE65084T1 (de) 1991-07-15
AU8125587A (en) 1989-05-18
AU617988B2 (en) 1991-12-12
JPH0699420B2 (ja) 1994-12-07
PT85157B (pt) 1990-03-30
FI91064B (sv) 1994-01-31
CY1783A (en) 1995-10-20
FI872807A (sv) 1987-12-27

Similar Documents

Publication Publication Date Title
DE69329712T2 (de) Tachykinin antagonistes
DE69332762T2 (de) Cathecoldiether als selektive pde iv hemmungsmittel
EP1202969B1 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
DE60312998T2 (de) 1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten
DE69716062T2 (de) Benzofuran-derivate und deren verwendung
DE602004011966T2 (de) Heterocyclylverbindungen
DE69031075T2 (de) 5-(1-aminocyclohexyl)-2(1h)-pyridinon und verwandte verbindungen
DD279674A5 (de) Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen
DE69214588T2 (de) Methanoanthracene als Dopaminantagonisten
DE68905845T2 (de) Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
DE69515177T2 (de) Tetrahydropyridinylmethylderivate von pyrrolo[2,3-b]pyridine
DE60006054T2 (de) Herstellungsverfahren für Pyridinderivate
DE68905216T2 (de) Hetera-aliphatische carboxamide.
DE3650567T2 (de) Medizinische Indol- und Indazol-Ketosulfonderivate
DE69621877T2 (de) 4-Indolylpiperazinyl-Derivate
DE69411589T2 (de) Indol, indolin und chinolin derivate mit einer 5ht1d antagonistischen wirkung
EP0250361B1 (de) Disubstituierte Piperazine
DE60311861T2 (de) Pyrazolochinoline mit immunmodulierender wirkung
EP0389425B1 (de) Neue Benzothiopyranylamine
DE60036081T2 (de) (1-phenacyl-3-phenyl-3-piperidylethyl)piperidinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP0879234A1 (de) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel
DE3779813T2 (de) 1,4-dihydropyridinderivate.
EP0213080B1 (de) Hydropyridin-Derivate
EP0322361A2 (de) Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
EP0266308A1 (de) Indolo-pyrazino-benzodiazepin-Derivate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee